Islamabad, Pakistan – Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®) has recently received registration approval from the Drug Regulatory Authority of Pakistan for its Firefighter™ PTCA Balloon Catheter (Firefighter™) and Foxtrot® Pro PTCA Balloon Catheter (Foxtrot® Pro) products.
Firefighter™ is made of flexible materials and its outer diameter allows extremely small balloons to pass through, so that two balloon catheters can be contained within a 5F guiding catheter, making it easier for physicians to perform complex operations, such as docking.
Designed for coronary dilation through percutaneous transluminal coronary angioplasty (PTCA), MicroPort® Firefighter™ PTCA Balloon Catheter can be used with the company’s Firehawk® Rapamycin Target Eluting Coronary Stent System for lesion dilation before stent implantation.
The approval of Firefighter™ and Foxtrot® Pro has expanded the coronary product offerings of MicroPort® in Pakistan and enables local patients access to a wider range of treatment solutions.
MicroPort® Foxtrot® Pro PTCA Balloon Catheter is also suitable for lesion dilation before stent implantation in PTCA procedures. Made of internationally advanced materials, the ultra-long hydrophilic coating significantly improves the crossing and pushing of catheters. The unique soft-tip design makes the balloon catheter tip more pliable, and advanced laser welding technology realizes seamless connection between the tip and the body of the catheter to provide additional solutions for complex lesion treatment.
With “people first” and “continuous innovation” staying at the core of its business philosophy, MicroPort® continues to provide innovative medical devices and integrated solutions to patients and physicians around the world.